| A few things are at play here. First, there are a number of different forms of HIV. HIV-1 is what's most prevalent in the US; HIV-2 is mostly restricted to sub-Saharan Africa, but a lot of HIV cases in Africa are HIV-1. (These can be broken down further - for example, there are about seven groupings of HIV-1 - but HIV-1 vs. HIV-2 is the most important distinction). Treatment for HIV-1 and HIV-2 can vary, and a lot less research has been done into the types of HIV that are common in Africa and India. Secondly, yes, AIDS (as opposed to HIV) is "mostly under control" in the US. There are still cases of AIDS in the US, but they tend to be in populations that are undertreated medically. For people who identify HIV early on, while their CD4s are still manageable, if they stick to a treatment regimen, they're far more likely to die from something else. In fact, people in the US who are HIV+ and under active treatment now live slightly longer lives than their HIV- counterparts. > Aids is the most easily preventable disease. AIDS is somewhat preventable (for people who already have HIV), but it requires an active and ongoing treatment regimen, as well as periodic medical care from a clinician. The funding for both of these is an issue, particularly in developing nations. HIV itself is somewhat preventable, though, which is why pre-exposure prophylaxis (PrEP) has been met with such excitement from HIV prevention efforts[0]. Not only is it over 99.9% effective[1], but it piggybacks off of the exact same drugs that are already used for treatment of HIV. It's much more effective to utilize the same distribution network for both treatment and prevention than it is to try to have separate efforts that exist side-by-side, but do very different work. [0] The AHF is the lone exception, but they've turned into the anti-vaxxers of HIV/AIDS prevention[2]. I don't consider them to be an HIV prevention group anymore; they've done far more work recently to worsen the HIV/AIDS epidemic than they have to stop it. [1] There has only been one infection recorded from a patient who was actively taking PrEP, and he was on an off-label treatment (PrEP is not approved for prophylactic purposes in his country), so it's unclear how typical his medication schedule was. [2] See in particular #2 and #3: http://www.hivplusmag.com/opinion/2015/06/24/op-ed-10-worst-... |
This sounded implausible, so I looked for a source. This page says "the average life expectancy of a 20-year-old person in the U.S. or Canada who began [anti-HIV therapy] shortly after he or she became HIV positive should be around 70", which is less than the life expectancy at birth of U.S. men:
http://www.catie.ca/en/treatmentupdate/treatmentupdate-200/a...
They do mention a plausible way for HIV-positive individuals to live longer, though: "compared to HIV-negative people, many HIV-positive people in Canada and similar countries are under a relatively high degree of medical scrutiny—they undergo visits to the clinic for interviews and laboratory tests several times each year. This degree of heightened medical surveillance is likely to detect any complications early on, before they can become serious"